HIGH DOSAGE HALOPERIDOL IN CHRONIC-SCHIZOPHRENIA

被引:45
作者
MCCREADIE, RG [1 ]
MACDONALD, IM [1 ]
机构
[1] GARTNAVEL ROYAL HOSP,GLASGOW G12 0XH,SCOTLAND
关键词
D O I
10.1192/bjp.131.3.310
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
引用
收藏
页码:310 / 316
页数:7
相关论文
共 20 条
[1]   A CONTROLLED CLINICAL-TEST OF A NEW PSYCHOLEPTIC DRUG (HALOPERIDOL) [J].
BRANDRUP, E ;
KRISTJANSEN, P .
JOURNAL OF MENTAL SCIENCE, 1961, 107 (449) :778-&
[2]  
COOPER JE, 1972, 20 MAUDSL MON
[3]  
Forsman A., 1974, NORD PSYKIATR TIDSSK, V28, P441, DOI [10.3109/08039487409097334, DOI 10.3109/08039487409097334]
[4]   CLOZAPINE AND HALOPERIDOL IN A SINGLE-BLIND CROSSOVER TRIAL - THERAPEUTIC AND BIOCHEMICAL ASPECTS IN TREATMENT OF SCHIZOPHRENIA [J].
GERLACH, J ;
KOPPELHUS, P ;
HELWEG, E ;
MONRAD, A .
ACTA PSYCHIATRICA SCANDINAVICA, 1974, 50 (04) :410-424
[5]  
GONER T, 1970, BEHAVIOURAL NEUROPSY, V2, P47
[6]  
HALL WB, 1968, DIS NERV SYST, V29, P405
[7]   A CONTROLLED TRIAL OF THIOPROPAZATE DIHYDROCHLORIDE (DARTALAN), CHLORPROMAZINE AND OCCUPATIONAL-THERAPY IN CHRONIC-SCHIZOPHRENICS [J].
HAMILTON, M ;
SMITH, ALG ;
LAPIDUS, HE ;
CADOGAN, EP .
JOURNAL OF MENTAL SCIENCE, 1960, 106 (442) :40-55
[8]   PERSISTENCE OF EXTRAPYRAMIDAL DISORDERS AND PSYCHIATRIC RELAPSE AFTER WITHDRAWAL OF LONG-TERM PHENOTHIAZINE THERAPY [J].
HERSHON, HI ;
KENNEDY, PF ;
MCGUIRE, RJ .
BRITISH JOURNAL OF PSYCHIATRY, 1972, 120 (554) :41-&
[9]  
HONIGFELD G, 1965, J CLIN PSYCHOL, V21, P65, DOI 10.1002/1097-4679(196501)21:1<65::AID-JCLP2270210122>3.0.CO
[10]  
2-I